ASHLEY BECHTEL: Open Payments
NPI 1215771720 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,415 in 118 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $1,109 · 2025 $4,415
Food & beverage: $2,533Travel & lodging: $1,821Education: $61
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $2,085 |
| ABBVIE INC. | 14 | $204 |
| Eisai Inc. | 15 | $200 |
| UCB, Inc. | 8 | $200 |
| Lilly USA, LLC | 9 | $186 |
| Merz Pharmaceuticals, LLC | 4 | $164 |
| SK Life Science, Inc. | 5 | $146 |
| JAZZ PHARMACEUTICALS INC. | 4 | $119 |
| Lundbeck LLC | 4 | $94 |
| Biogen, Inc. | 4 | $93 |
Products named: INFINITY, PROCLAIM, Fintepla, KISUNLA, INBRIJA, Leqembi, VYEPTI, XYWAV.
Industry payments across MD — which companies pay providers there.
